r Low intrinsic aerobic capacity is associated with increased all-cause and liver-related mortality in humans.
Introduction
Aerobic capacity, also termed cardiorespiratory fitness, is the most powerful predictor of cardiovascular and all-cause mortality independent of other major risk factors (Myers et al. 2002) . Low aerobic capacity is also an independent predictor for multiple metabolic disease states including non-alcoholic fatty liver disease (NAFLD; Church et al. 2006) . Aerobic capacity is substantially reduced in NAFLD patients (Croci et al. 2012) , and low initial aerobic capacity negatively impacts lifestyle-induced treatment of NAFLD (Kantartzis et al. 2009 ), increases mortality in chronic liver disease patients, and reduces survivability following liver transplant (Bernal et al. 2014) . However, potential mechanisms by which aerobic capacity mediates susceptibility to NAFLD and liver disease are not well understood.
High calorie, high fat diets (HFD) are associated with NAFLD risk and obesity in humans and are commonly utilized to induce hepatic steatosis in rodent models. However, chronic HFD-induced hepatic steatosis does not progress to non-alcoholic steatohepatitis (NASH) in rodent models (Matteoni et al. 1999 ), whereas we and others have shown that the addition of refined sugar and/or cholesterol to an HFD induces NASH-like outcomes (Gan et al. 2014; Bashiri et al. 2016; Linden et al. 2016) . Inappropriate cholesterol metabolism has received considerable attention in human and animal studies of NAFLD, and has been observed to modulate multiple pathways triggering NASH development (Min et al. 2012; Arguello et al. 2015) . In support of these findings, large epidemiological reports link elevated cholesterol consumption with increased risk of NASH (Musso et al. 2003) . Therefore, both intrinsic aerobic capacity and western diet (WD; high in fat, sugar and cholesterol) clearly impact prevalence and progression of NAFLD severity including the transition to NASH, but the interaction of these factors has never been examined.
In order to assess the role of intrinsic aerobic capacity in modulating the susceptibility to WD-induced NASH, we utilized the high capacity runner (HCR)/low capacity runner (LCR) rat model system created by selective breeding for divergent intrinsic aerobic capacities (Koch & Britton, 2001; Ren et al. 2013) . We have previously shown that low intrinsic aerobic capacity increases susceptibility for hepatic steatosis under chow and acute and chronic HFD conditions (increased lipids and sucrose), effects we have attributed to robust reductions in hepatic mitochondrial content, mitochondrial fatty acid oxidation (FAO) and mitochondrial respiratory capacity (MRC) in LCR vs. HCR rats (Thyfault et al. 2009; Morris et al. 2014 Morris et al. , 2016 . The robust differences in hepatic mitochondrial oxidative capacity play a role in the larger whole body differences in energy metabolism in the HCR/LCR rats that has been described by Britton, Koch and colleagues as the 'energy transfer hypothesis' . The hypothesis contends that high vs. low aerobic capacity leads to a greater rate of thermogenesis or metabolic entropy, and is supported by evidence that HCR rats have higher body and skeletal muscle temperature, higher resting energy expenditure, and greater mitochondrial metabolism in skeletal muscle and adipose. Here we tested the hypothesis that reduced intrinsic aerobic capacity and associated reductions in hepatic mitochondrial content, FAO and MRC would result in increased susceptibility for NASH in the LCR rats while the high-fitness HCR rats that display elevations in these hepatic mitochondrial features would be protected.
Methods

Animals
HCR/LCR rat development and characterization were previously described (Koch & Britton, 2001; Wisloff et al. 2005; Noland et al. 2007; Thyfault et al. 2009; Novak et al. 2010; Gavini et al. 2014; Morris et al. 2014; Vieira-Potter et al. 2015) . Male rats (Generation 35) 25-30 weeks of age were singly housed (ß25°C, 12-hour light cycle) with ad lib access to water, and acclimatized to the low-fat, control diet (LFD) (D12110704; 10% kcal fat, 3.5% kcal sucrose, 3.85 kcal g −1 ; Research Diets, Inc., New Brunswick, NJ, USA) for 2 weeks prior to the initiation of the western diet (WD) (D09071604; 45% kcal fat, 17% kcal sucrose, 1% cholesterol w/w, 4.68 kcal g −1 ; Research Diets, Inc.). Food intake and body weight were monitored weekly during a 16-week dietary intervention (n = 8 in each group). Animals were anaesthetized with pentobarbital (75 mg kg −1 , I.P.) prior to killing by exsanguination and bilateral thoracotomy. Tissues were collected and snap frozen in liquid nitrogen after an overnight fast. The animal protocols were approved by the Institutional Animal Care and Use Committee at the University of Missouri and the Subcommittee for Animal Safety at the Harry S. Truman Memorial VA Hospital.
Body composition analysis
Body composition was measured by magnetic resonance using the EchoMRI-900 analyser (EchoMRI, Houston, TX, USA). Body composition was determined before the initiation of WD and periodically throughout the 16-week dietary intervention.
Liver lipid analysis
Liver triacylglycerol concentration was determined as previously described using a commercially available kit (F6428, Sigma-Aldrich, St Louis, MO, USA) (Thyfault et al. 2009 ). Liver cholesterol was determined utilizing a commercially available kit (ab65359, Abcam, Cambridge, MA, USA).
Liver histochemical staining
Haematoxylin and eosin (H&E) staining was performed as described previously (Rector et al. 2010) .
Mitochondrial isolation
Mitochondria were isolated from rat liver tissue, as previously described (Morris et al. 2012) . Briefly, tissue was homogenized (Teflon on glass) in cold liver mitochondrial isolation buffer (220 mannitol, 70 sucrose, 10 mM Tris, and 1 mM EDTA, adjusted to pH 7.4 with KOH) and centrifuged (1500 g, 10 min, 4°C). The supernatant was serially centrifuged (8000 g-6000 g-4000 g, 10 min, 4°C), with the pellet resuspended (glass on glass) in liver mitochondrial isolation buffer following each centrifugation. The protein concentration was determined by bicinchoninic acid assay.
Mitochondrial respiration
Mitochondrial oxygen consumption was measured using a Clark-type electrode system (Strathkelvin Instruments, North Lanarkshire, UK) as previously described (Morris et al. 2013) . The consumption of oxygen in nmol min
was normalized to mitochondrial protein in the respirometer cell.
Palmitate oxidation by liver homogenate
The oxidation of [1-14 C]palmitate was measured in fresh liver homogenates as previously described (Morris et al. 2012) . Fatty acid oxidation was assessed by measuring the production of 14 CO 2 (complete FAO) and 14 C-acid-soluble metabolites in a sealed trapping device at 37°C containing palmitate (200 μM). In order to approximate the carnitine palmitoyltransferase I (CPT-1)-mediated and non-CPT-1-mediated FAO in the liver homogenate, parallel incubations were included with the CPT-I inhibitor etomoxir (100 μM). One animal for each group was analysed daily. Values were normalized to the wet weight of the liver tissue sample.
Pyruvate oxidation by isolated mitochondria
The oxidation of 5 mM pyruvate ([2- 14 C]pyruvate) to 14 CO 2 by isolated liver mitochondria was used to monitor pyruvate oxidation and approximate tricarboxylic acid (TCA) cycle flux as previously described (Morris et al. 2012) .
Acyl-carnitine analysis
Plasma and liver acyl-carnitines were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) on an API 3200 triple quadrupole mass spectrometer (Applied Biosystems/Sciex Instruments, Foster City, CA, USA) as previously described (Satapati et al. 2012) . Briefly, liver and plasma free carnitine and acyl-carnitines were extracted, derivatized, and individual acyl-carnitine peaks were then quantified by comparison with a 13 C internal standard (Cambridge Isotopes, Andover, MA, USA). Liver metabolites were normalized to tissue sample weight.
Citrate synthase activity
Citrate was determined as previously described (Srere, 1969) . Values were normalized to the wet weight of the liver tissue sample.
Liver nucleotides
Liver ATP, ADP and AMP were measured by mass spectrometry as described previously (Satapati et al. 2015) . 
AAGAGGAGTGGATAGGTTTA CTGTCTTTGATGGAGTAGAAC multiple reaction monitoring. Liver nucleotides were normalized to tissue sample weight. Liver energy charge was calculated as (
Western blotting
Triton X-100 cell lysates were used to produce Western blot-ready Laemmli samples. Samples were separated by SDS-PAGE, transferred to polyvinylidene difluoride membrane and probed with primary antibodies. Bcl-2, Bcl-xL, Bax, Bak, caspase 3 and caspase 7 antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). HADHA antibody was purchased from Abcam. CPT-1a antibody was purchased from Proteintech Group, Inc. (Rosemont, IL, USA). Individual protein bands were quantified using a densitometer (Bio-Rad Laboratories, Hercules, CA, USA) and protein loading was corrected by 0.1% amido-black (Sigma-Aldrich) staining to determine total protein as previously described (Morris et al. 2012) .
mRNA expression
RNA and cDNA were prepared as previously described (Morris et al. 2013 50.8 ± 6.9 82.7 ± 9.7 † 34.1 ± 7.1 88.9 ± 14.2 † Body fat % 19.3 ± 1.5 21.6 ± 1.5 24.6 ± 1.7 * 26.8 ± 1.5 * Change in body fat % 5.5 ± 1.2 6.3 ± 0.8 6.9 ± 0.9 10.2 ± 0.4 * * , † † Energy intake (weekly average, kcal) a 387.8 ± 15.5 431.5 ± 10.6 † † 394.7 ± 22.3 424.9 ± 18.9 Feed efficiency (weekly average, mg kcal −1 ) b 9.3 ± 1.4 11.4 ± 1.4 6.4 ± 1.5 11.9 ± 1.4 † † Liver weight (g) 9.2 ± 0.5 18.2 ± 1.2 † 9.9 ± 0.6
86.1 ± 6.4 92.1 ± 16.7 98.1 ± 7.9 134.0 ± 8.6 * * , † † Plasma Glucose (mg dl −1 ) 169.1 ± 8.5 174.5 ± 7.4 172.5 ± 9.9 167.9 ± 5.1 Insulin (ng ml −1 )
1 . 3 9 ± 0.18 1.47 ± 0.19 1.08 ± 0.17 1.37 ± 0.21
Data are means ± SEM (n = 8). a Average weekly energy intake during the 16 weeks' diet. b Weekly feed efficiency as weekly body weight gain divided by weekly energy intake. * P < 0.05 main effect HCR vs. LCR; †P < 0.05 main effect LFD vs. WD; * * P < 0.05 HCR vs. LCR within diet; † †P < 0.05 LFD vs. WD within strain. ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate aminotransferase.
Statistical analysis
Animals within strain were randomized by weight into the two dietary groups. The main effects of phenotype and diet were tested by using 2-way ANOVA (SPSS Statistics, IBM, Armonk, NY, USA). Where significant main effects were observed, post hoc analysis was performed using least significant difference to test for any specific pairwise differences. Statistical significance was set at P < 0.05.
Results
Animal characteristics
Final body weight was ß16% less in HCR compared to LCR rats regardless of diet (Table 2 , P < 0.05). However, 16 weeks of WD produced significant weight gain in both HCR and LCR rats compared to LFD (ß60% in each strain, P < 0.05). The LCR rats displayed ß20% higher body fat percent than HCR rats across all diets (P < 0.05). Interestingly, WD caused no change in body fat percent in the HCR rats, but caused a ß50% increase in the LCR rats (P < 0.05). WD significantly increased liver weight in both HCR and LCR rats compared to LFD (ß2 fold in each strain, P < 0.05).
Fasting serum and plasma
Circulating glucose and insulin (Table 2) were not different among groups. WD resulted in a significant > 2-fold increase in aspartate aminotransferase (AST) in both strains and a 2-fold and 4-fold increase in alanine transaminase (ALT) in HCR and LCR rats, respectively (P < 0.05), representing a ß60% greater ALT in LCR compared to HCR rats (P < 0.05). Alkaline phosphatase (ALP) levels were ß40% lower in LCR compared to HCR rats on LFD (P < 0.05), and only LCR rats displayed an increase following WD (67%, P < 0.05). Finally, the WD diet increased serum cholesterol levels only in the LCR rats (37%, P < 0.05). In summary, reduced intrinsic aerobic capacity results in WD-induced increases in body fat and serum markers of liver damage.
Liver histology and lipid analysis
Liver H&E images show increased steatosis in both strains following chronic WD (Fig. 1A) ; however, the LCR rats displayed greater increases in inflammatory cell infiltration than the HCR rats following WD feeding. While differences in fibrosis markers, namely transforming growth factor β (TGFb) and collagen, type I, α 1 (Col1a1) mRNA expression, were observed due to the WD in both strains (data not shown), no difference was observed in picosirius red staining for fibrosis due to either strain or diet. Unlike previous observations (Thyfault et al. 2009; Morris et al. 2014 Morris et al. , 2016 , liver triacylglycerol (TAG) content was found to be higher in HCR compared to LCR rats on LFD ( in liver TAG and increases in liver weight in both strains (P < 0.05). The HCR rats maintained 38% greater liver TAGs compared to LCR rats after the WD diet (P < 0.05). Total liver cholesterol was increased ß3-fold in both strains following WD (Fig. 1B , P < 0.05), and hepatic free cholesterol was increased 67% in HCR and 45% in LCR rats (P < 0.05). Hepatic cholesterol esters robustly increased in both groups following WD (16-and 29-fold, respectively, P < 0.05), but were 32% higher in LCR than HCR rats after WD (interaction, P < 0.05). We next examined expression of several genes (i.e. those for cholesterol metabolism, bile acid synthesis/ steroidogenesis, and cholesterol/bile acid transporters) that may be responsible for strain or diet differences in liver cholesterol ester levels (Table 3) . Several genes (e.g. HMGCR, SOAT2, CYP7a1, HSD17b and ABCA1) displayed significant changes in expression between the LCR and HCR rats following chronic WD (significant interactions, P < 0.05), implicating intrinsic aerobic capacity as a modulator of liver sterol homeostasis. These data show that while HCR and LCR rats both display WD-induced steatosis, the LCR rats with reduced intrinsic aerobic capacity are much more susceptible to hepatic cholesterol ester storage and inflammatory cell infiltration.
Liver inflammation
We next examined hepatic expression of genetic markers of white cell infiltration, recruitment/activation, and initiation/propagation of inflammatory signals. Liver mRNA expression of macrophage marker F4/80 was only increased in the WD-fed LCR rats ( Fig. 2A, ß3 -fold, interaction, P < 0.05). In addition, WD resulted in more dramatic increases in monocyte chemoattractant protein 1 (MCP-1), IL-1β, and the toll-like receptors 2, 4, and 9 (TLR2, 4 and 9) in LCR compared to HCR rats ( Fig. 2B and C, significant interactions, P < 0.05). Hepatic expression of death receptors TRAIL2, Fas and TNFR1 were all increased in LCR WD compared to LFD and HCR WD rats (Fig. 2D , P < 0.05). Furthermore, significant WD-induced increases in liver inflammatory gene expression of NLRP3, TNFa, CD11c, CD68 and CD64 were observed in both strains J Physiol 595.14 (Table 3) , with no effects of strain observed. These data show that intrinsic aerobic capacity significantly alters susceptibility to WD-induced NASH outcomes.
Liver fatty acid oxidation and acyl-carnitine profiles
We have previously shown that decreased intrinsic aerobic capacity is associated with reduced liver complete fatty acid oxidation (FAO) and more pronounced NAFLD outcomes (Rector et al. 2008; Thyfault et al. 2009; Morris et al. 2012 Morris et al. , 2014 Morris et al. , 2016 . To further assess the role of intrinsic aerobic capacity and chronic WD on liver lipid oxidation, we performed FAO experiments in liver homogenate and determined liver and plasma acyl-carnitine profiles. Chronic WD resulted in a ß45% reduction of complete FAO in both strains (Fig. 3A , P < 0.05), with the HCR WD rats maintaining a 33% greater complete FAO to CO 2 compared to LCR rats (P < 0.05). WD resulted in a significant decrease in acid-soluble metabolite (ASM) production in both strains (HCR, 6%; LCR, 18%; P < 0.05), but a larger decrease in LCR than HCR rats (interaction, P < 0.05). These changes were not due to changes in protein expression of CPT-1a, (Fig. 3D) . However, both complete FAO and ASM production appear to associate with total HADHA (trifunctional enzyme subunit a, mitochondria) protein expression, which was lower in the LCR rats on LFD and was reduced in both groups by the WD (Fig. 3D , P < 0.05). While up to 90% of liver FAO is localized to the mitochondria, the impact of increased peroxisomal β-oxidation on liver disease initiation and progression has not been extensively studied. To approximate peroxisomal FAO, liver homogenate FAO was determined in the presence of the CPT-1 inhibitor etomoxir. In the presences of etomoxir, the relative differences for all FAO data (Fig. 3B ) strongly mirrored the absolute values above. Complete FAO due to peroxisomal oxidation was ß40% higher in the HCR compared to LCR rats regardless of diet (P < 0.05) and ASM production from peroxisomes was also higher in HCR rats on LFD (P < 0.05). WD lowered peroxisomal ASM production only in the HCR but not the LCR rats (P < 0.05). These data suggest that intrinsic aerobic capacity impacts liver peroxisomal FAO and may impact susceptibility for liver disease.
Acyl-carnitine profiling was performed in liver and plasma to further characterize the role of differing intrinsic aerobic capacity upon lipid metabolism, (Fig. 3C and Table 4 ). WD produced a significant decrease in the C2/C4 acyl-carnitine ratio compared to LFD (P < 0.05) in both strains due to increases in C4-carnitine. However, the change in C2/C4 was significantly greater following WD in the HCR than the LCR rats (interaction, P < 0.05). An opposite effect was observed for the C4/C16 acyl-carnitine ratio, where it was increased in both groups following WD, but was increased to a greater extent in the LCR rats (P < 0.05). A decrease in the C2/C4 and an increase in the C4/C16 acyl-carnitine ratios suggest a decrease in complete fatty acid oxidation and/or an increase in β-oxidation leading to the subsequent accumulation of short-chain C4-carnitine. Additionally, liver long-chain (C14 and C16) acyl-carnitine levels were lower in the LCR compared to HCR rats, and were lowered in both strains following WD exposures (P < 0.05). Further, medium-chain (C8) acyl-carnitines were lowered by WD in both strains (P < 0.05). In addition to implicating increased liver β-oxidation of these species following chronic WD, the lower liver levels of medium-and long-chain acyl-carnitines also may suggest greater diversion of excess liver acyl-CoAs toward the TAG synthesis pathway. This interpretation is supported by the gross steatosis observed in both strains on the WD. Hepatic free carnitine decreased following WD in both strains (Table 4 , P < 0.05), but the reduction was significantly greater in the LCR vs. HCR rats (interaction, P < 0.05). WD diet caused an equal increase in plasma free carnitine in both strains suggesting that hepatic tissue metabolism following WD was different between strains. Plasma and liver C2-carnitine patterns were similar in the HCR rats on both diets but the WD significantly decreased liver C2-carnitine in the LCR rats. All told, these data demonstrate that reduced intrinsic aerobic capacity is associated with decreased hepatic FAO and FAO adaptability to the WD challenge.
Liver mitochondrial content, respiration and energy state
Reductions in hepatic mitochondrial number, mitochondrial respiratory capacity (MRC), and energy state have also been implicated in the development of NAFLD (Begriche et al. 2013; Arguello et al. 2015) . Hepatic mitochondrial content, assessed by citrate synthase activity, was reduced 23% by WD in both strains ( Fig. 4A , P < 0.05); however, content remained 16% higher in the HCR than LCR rats (P < 0.05). We previously reported (Morris et al. 2014 Fig. 4A , P < 0.05). Similarly, WD feeding reduced ADP-stimulated mitochondrial respiration of glutamate through complex I and complex I and II to a greater extent in LCR vs. HCR rats (Fig. 4B , P < 0.05), whereas, maximal uncoupled mitochondrial respiration of glutamate was significantly increased following WD feeding in HCR compared with LCR rats (Fig. 4B , P < 0.05). Mitochondrial respiration experiments with pyruvate and palmitoyl-carnitine produced similar findings (data not shown).
Because of differences in hepatic FAO and MRC, we also measured hepatic energy status (NAD and adenine nucleotide pools). LCR rats displayed greater NADH than HCR rats on LFD (Table 5 , P < 0.05). WD significantly reduced NAD + , NADH, total NAD, AMP, ADP, ATP and total nucleotides in both strains (P < 0.05). To reduce the impact of WD-induced hepatomegaly on the interpretation of these findings, we calculated within liver sample NAD + /NADH ratio and adenine energy state. Interestingly, no difference due to strain or diet was observed in hepatic energy charge as calculated from adenine nucleotides (Fig. 4C) . WD significantly lowered NAD + /NADH in both strains (P < 0.05). Importantly, the greater NADH of the LCR rats (Table 5 ) resulted in a lower liver NAD + /NADH ratio compared to HCR rats on both diets (Fig. 4C , P < 0.05). Chronically reduced NAD + /NADH within the LCR rats is suggestive of greater oxidative stress (Fisher-Wellman & Neufer, 2012) , which was further supported by higher hepatic lipid peroxidation (4-HNE) and evidence of hydrogen peroxide handling (GPx1) in the LCR over HCR rats (Fig. 5, P < 0.05) . In total, these data show that low intrinsic aerobic capacity tracks with reduced liver mitochondrial content, TCA cycle flux and respiratory capacity that is worsened with a WD. In addition, low-fitness LCR rats displayed a more reduced oxidative state, particularly following chronic WD feeding.
Liver mitochondrial integrity and effector caspase activation
Mitochondria serve as a primary cellular site for regulation and integration of intra-and extracellular signals modulating inflammatory and cell death signalling (Guicciardi et al. 2013) . We measured hepatic mitochondrial specific content of Bcl-2 family proteins involved in regulating mitochondrial outer membrane permeability (MOMP) and downstream effector caspases to assess the impact of divergent aerobic capacity and WD on these portions of the cell death cascade. Mitochondrial content of the anti-apoptotic protein Bcl-2 was increased, while Bcl-xL was decreased by WD in both strains (Fig. 6A , P < 0.05). Pro-apoptotic Bcl-2 family members, Bax, Bak and cleaved Bcl-xL, were all significantly increased following WD in both strains (Fig. 6B, P < 0.05) . Interestingly, cleaved Bcl-xL mitochondrial localization was greater in LCR rats on both LFD and WD (29% and 39%, respectively) compared to HCR rats.
To assess whether these elevated markers of mitochondrial outer membrane permeability were associated with activation of downstream pathways, caspase 3 and 7 protein activation status was determined (Fig. 6C ). Both J Physiol 595.14 caspase 3 and 7 showed greater activation in the LCR compared to HCR rats regardless of diet (ß60% and 4-fold, respectively, P < 0.05). WD increased activation of caspase 3 but not 7 in HCR and LCR rats (39% and 48%, respectively, P < 0.05). Thus, WD-induced changes in hepatic mitochondrial integrity between rats with divergent intrinsic aerobic capacities do not result in similarly associated changes in caspase activation. Further, selection for low aerobic capacity is associated with greater basal activation of hepatic effector caspases, which is exacerbated by chronic WD feeding.
Discussion
Despite numerous findings in humans that aerobic capacity impacts liver disease progression, mechanisms remain unknown. Likewise, factors that drive transition from NAFLD to NASH in only a proportion of patients remain unknown. Here, we find low aerobic fitness and reduced initial hepatic mitochondrial oxidative capacity enhance susceptibility to WD-induced NASH, as characterized by increased serum ALT, inflammatory cell infiltration, effector caspase activation, and mRNA expression of pro-inflammatory and cell death signalling genes. Importantly, evidence of transition to NASH was only found in the low-fitness LCR rats despite both high-fitness HCR and low-fitness LCR rats developing robust hepatomegaly and steatosis. Overall, the data show that intrinsic aerobic capacity and hepatic mitochondrial oxidative capacity impact cholesterol ester accumulation and inflammatory status following WD, and support the concept that these physiological factors drive risk for transition from NAFLD to NASH. The roles of both maladaptive liver cholesterol metabolism and hepatic mitochondrial function have been widely investigated in the development of NAFLD (Min et al. 2012; Arguello et al. 2015; Bashiri et al. 2016) . Excess dietary cholesterol results in hepatomegaly and steatosis, reduced liver complete and total FAO, and decreased ADP-coupled mitochondrial respiration in rats (Rogers et al. 1980; Fungwe et al. 1993) , while chemical inhibition of endogenous cholesterol synthesis increased hepatic mitochondrial and peroxisomal FAO with protection from NASH development (Roglans et al. 2002; Park et al. 2016 ). In the current study, WD reduced FAO (complete and incomplete) and MRC in both strains, but the LCR rats started at a lower level and remained lower than HCR rats. In addition, the impact of the lower levels of FAO and MRC in isolated mitochondria is further magnified by the overall lower mitochondrial content in the LCR vs. HCR rats. Similar findings were observed with markers of liver mitochondrial content, TCA cycle flux and free hepatic carnitine content. We have previously observed that LCR rats have increased susceptibility to steatosis, which was associated with reduced whole body FAO, metabolic inflexibility, decreased liver FAO and reduced MRC (Thyfault et al. 2009; Morris et al. 2014 Morris et al. , 2016 . These data are similar to human NAFLD subjects who have been shown to have physiological features that include lower aerobic capacity, metabolic inflexibility, decreased whole body FAO, and reduced β-hydroxybutyrate, all factors that suggest reduced liver FAO capacity (Croci et al. 2012) . Additional rodent studies have demonstrated that reduced hepatic complete FAO is associated with development and progression of hepatic steatosis (Rector et al. 2008 (Rector et al. , 2010 while molecular therapies to enhance FAO effectively treat or prevent steatosis. Importantly, our findings of greater WD-induced reductions in mitochondrial FAO and MRC in LCR rats appear to be independent of TAG accumulation, suggesting that hepatic TAG stores are not the primary driver of inflammation and oxidative stress, but rather that hepatic mitochondrial function plays a more important role. These results are similar to the athletes' paradox by which both athletes and insulin-resistant obese individuals display dramatically different insulin sensitivity and inflammation despite both displaying elevated intramuscular lipids (Goodpaster et al. 2001) . Much like in muscle, it is the possible that the overall balance of hepatic mitochondrial content/oxidative capacity and lipid stores interact to impact outcomes related to inflammation and insulin resistance. Mitochondria are hypothesized to serve as a cellular point of integration of intra-and extracellular signals ultimately producing inflammation and cell death signalling (Guicciardi et al. 2013; Luedde et al. 2014; Arguello et al. 2015) . Dysregulated liver cholesterol homeostasis and accumulation has been implicated in the initiation of hepatic mitochondrial dysfunction (Montero et al. 2010) , which is associated with NAFLD severity (Min et al. 2012) . Mitochondrial membranes are inherently cholesterol poor (Montero et al. 2010) , with increased mitochondrial membrane cholesterol producing decreased ATP synthesis (Campbell & Chan, 2007) and decreased mitochondrial antioxidant capacity (Fernandez-Checa & Kaplowitz, 2005) . In the present study, maximal ADP-coupled MRC was lowered to a greater extent following WD in the LCR rats, results that tracked with greater induction of mitochondrial oxidative stress. Previously, increased free cholesterol levels were highly associated with NASH-related mitochondrial dysfunction (Min et al. 2012; Gan et al. 2014) . Interestingly, here the reductions in MRC and increased markers of oxidative stress occurred in parallel with an observed increase in cholesterol ester in LCR compared to HCR rats on the WD. Chronic accumulation of mitochondrial cholesterol is associated with increased mitochondrial localization of pro-apoptotic Bcl-2 family members and activation of MOMP (Montero et al. 2010) . Chronic WD feeding in this study resulted in similar increases in mitochondrial protein localization of Bax and Bak in both strains, while lowering the predominant liver anti-MOMP Bcl family member, Bcl-xL. Mitochondrial localization of the pro-apoptotic Bcl-xL cleavage product (Clem et al. 1998; Fujita et al. 1998) was significantly higher in the WD-fed LCR rats compared to HCR rats, and was strongly associated with the observed increases in markers of advance NAFLD.
We found that effector caspase activation was higher in LCR compared to HCR rats regardless of diet, with WD dramatically increasing caspase-3 activation further. This increase in caspase-3 activation could potentially explain the observed increase in cleaved Bcl-xL (Clem et al. 1998; Fujita et al. 1998) . The increased effector caspase activation also suggests greater intrinsic/extrinsic cell death signalling in the LCR on WD, which is further supported by the observed increases in cell death receptor expression. As mentioned, there is considerable evidence that loss of mitochondrial function and excess cholesterol can result in propagation of these intrinsic/extrinsic cell death signals (Guicciardi et al. 2013; Luedde et al. 2014; Arguello et al. 2015) . However, any increased cell death signalling in the LCR rats on WD is early in the disease process as assessment of cell death by TUNEL assay showed no differences between HCR and LCR rats (data not shown). Together, these data suggest that intrinsically low aerobic capacity results in increased susceptibility to WD-induced steatohepatitis due to lower mitochondrial respiratory capacity, increased oxidative stress and greater activation of effector caspases.
In summary, we demonstrate that intrinsic aerobic capacity impacts susceptibility for WD-induced NASH. Lower initial levels and further declines in liver FAO and MRC paired with excessive liver cholesterol ester accumulation lead to greater increases in several markers of liver damage and inflammation in the low-fitness LCR compared to the high-fitness HCR rats. Of note, while high intrinsic aerobic capacity HCR rats were less susceptible to many of the liver mal-adaptations induced by a WD, HCR rats were not completely protected against hepatomegaly/liver TAG accumulation or against a loss of mitochondrial FAO or MRC unlike our previous findings with acute and chronic high-fat diets (Thyfault et al. 2009; Morris et al. 2014 Morris et al. , 2016 . These data support a novel concept that aerobic capacity and hepatic mitochondrial phenotype may play a critical role J Physiol 595.14 in whether NAFLD transitions to NASH, links that require further examination in human patients. Overall, these data provide new insight into how intrinsic aerobic capacity may influence the onset and progression of metabolic disease through hepatic mitochondrial oxidative capacity.
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